Disease Area Partner in Medical and Scientific Affairs (MSA), Roche Diagnostics
BIOGRAPHY
Dr. Jim Richter and Dr. Clara Latorre will walk through the ever changing landscape of cervical screening and management. Cervical screening supports both pap cytology and HPV testing, depending on age, access and history. Risk stratification can be difficult with discrepant results. With recent ASCCP management guideline updates to include dual-stain biomarker as an acceptable triage method, we will walk through how dual-stain biomarker testing works and how it can enable confidence in patient management.
Upon conclusion of this presentation we expect you will: